SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 139 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $162,557 | -16.2% | 7,918 | -2.8% | 0.00% | – |
| Q1 2024 | $193,875 | +16.1% | 8,146 | +5.4% | 0.00% | – |
| Q4 2023 | $167,046 | +147.6% | 7,730 | +66.3% | 0.00% | – |
| Q3 2023 | $67,475 | -27.9% | 4,647 | +4.0% | 0.00% | – |
| Q2 2023 | $93,557 | -2.5% | 4,470 | -1.6% | 0.00% | – |
| Q1 2023 | $95,949 | -12.9% | 4,543 | +4.9% | 0.00% | – |
| Q4 2022 | $110,199 | +6.0% | 4,330 | 0.0% | 0.00% | – |
| Q3 2022 | $104,000 | +25.3% | 4,330 | 0.0% | 0.00% | – |
| Q2 2022 | $83,000 | +10.7% | 4,330 | 0.0% | 0.00% | – |
| Q1 2022 | $75,000 | -21.1% | 4,330 | 0.0% | 0.00% | – |
| Q4 2021 | $95,000 | +14.5% | 4,330 | 0.0% | 0.00% | – |
| Q3 2021 | $83,000 | +12.2% | 4,330 | 0.0% | 0.00% | – |
| Q2 2021 | $74,000 | -23.7% | 4,330 | 0.0% | 0.00% | – |
| Q1 2021 | $97,000 | +1.0% | 4,330 | 0.0% | 0.00% | – |
| Q4 2020 | $96,000 | +50.0% | 4,330 | 0.0% | 0.00% | – |
| Q3 2020 | $64,000 | 0.0% | 4,330 | 0.0% | 0.00% | – |
| Q2 2020 | $64,000 | +33.3% | 4,330 | 0.0% | 0.00% | – |
| Q1 2020 | $48,000 | +26.3% | 4,330 | 0.0% | 0.00% | – |
| Q4 2019 | $38,000 | +18.8% | 4,330 | 0.0% | 0.00% | – |
| Q3 2019 | $32,000 | -20.0% | 4,330 | 0.0% | 0.00% | – |
| Q2 2019 | $40,000 | +73.9% | 4,330 | 0.0% | 0.00% | – |
| Q1 2019 | $23,000 | +21.1% | 4,330 | 0.0% | 0.00% | – |
| Q4 2018 | $19,000 | -45.7% | 4,330 | 0.0% | 0.00% | – |
| Q3 2018 | $35,000 | +16.7% | 4,330 | 0.0% | 0.00% | – |
| Q2 2018 | $30,000 | -51.6% | 4,330 | 0.0% | 0.00% | – |
| Q1 2018 | $62,000 | +63.2% | 4,330 | 0.0% | 0.00% | – |
| Q4 2017 | $38,000 | -25.5% | 4,330 | 0.0% | 0.00% | – |
| Q3 2017 | $51,000 | – | 4,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
| Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
| Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
| BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
| FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
| Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
| Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
| PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |